Items where authors include "Marjot, T."

Article

Goodyear, C.S., Patel, A., Barnes, E. et al. (118 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Goodyear, C.S., Patel, A., Barnes, E. et al. (119 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Murray, S.M. orcid.org/0000-0002-5990-5854, Pose, E., Wittner, M. et al. (36 more authors) (2024) Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients. Journal of Hepatology, 80 (1). pp. 109-123. ISSN 0168-8278

Tavabie, O.D., Abbott, J., Abeysekera, K.W.M. et al. (97 more authors) (2024) Regional variations in inpatient decompensated cirrhosis mortality may be associated with access to specialist care: results from a multicentre retrospective study. Frontline Gastroenterology, 15 (1). pp. 3-13. ISSN 2041-4137

Tavabie, O.D., Abbott, J., Abeysekera, K.W. et al. (97 more authors) (2023) Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis. Journal of Hepatology, 79 (4). e165-e167. ISSN 0168-8278

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine. ISSN 1078-8956

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29 (7). pp. 1760-1774. ISSN 1078-8956

Tavabie, O.D., Abeysekera, K.W.M., Brennan, P.N. et al. (291 more authors) (2023) Regional variation in characteristics of patients with decompensated cirrhosis admitted to hospitals in the UK. The Lancet Gastroenterology & Hepatology, 8 (7). pp. 604-606. ISSN 2468-1253

Othonos, N. orcid.org/0000-0002-9988-6328, Pofi, R. orcid.org/0000-0001-7808-5735, Arvaniti, A. et al. (28 more authors) (2023) 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial. Nature Communications, 14. 1025. ISSN 2041-1723

Shribman, S., Marjot, T., Sharif, A. et al. (12 more authors) (2022) Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver. The Lancet Gastroenterology & Hepatology, 7 (6). pp. 560-575. ISSN 2468-1253